Last updated: August 3, 2025
Introduction
South Korean patent KR20180085049, filed under the Korean Intellectual Property Office (KIPO), addresses innovations in the pharmaceutical domain, often linked to specific drug compositions, formulations, or methods of manufacture. This patent plays a strategic role in securing market exclusivity, preventing patent infringement, and establishing a competitive edge within Korea’s robust pharmaceutical sector. This analysis explores the patent’s scope, claims, and the broader patent landscape affecting similar drug innovations.
Patent Overview
Patent Number: KR20180085049
Filing Date: August 17, 2018
Priority Date: (assumed prior to filing date, specific details not available here)
Inventors/Applicants: Normally associated with a pharmaceutical company or research institution (exact assignee details would be necessary for complete assessment).
Purpose: The patent likely aims to protect a novel drug formulation, process, or use related to a therapeutic compound or class.
Scope of the Patent
The scope encompasses the protected subject matter, typically delineated by the claims. It covers innovations that are novel, inventive, and industrially applicable within Korea, possibly extending to related jurisdictions through patent family arrangements.
Key aspects include:
- Formulation or composition: A specific combination of active pharmaceutical ingredients (APIs) with particular excipients, delivery systems, or stabilizers.
- Method of preparation or manufacturing: Innovative processes enhancing yield, purity, or stability.
- Therapeutic use or methods: Novel indications, dosing regimens, or treatment protocols utilizing the composition or compound.
The scope remains bounded by the claims' language, which defines rights over specific compounds, formulations, and processes.
Claims Analysis
The claims, both independent and dependent, articulate the legal boundaries of patent protection. Here, a typical structure involves:
1. Independent Claims
These establish broad protection, such as:
- A novel pharmaceutical composition comprising a specific active ingredient or combination, characterized by particular ratios, stability profiles, or delivery modes.
- A method of treatment involving administering the composition to treat a disease or condition, defined by specific parameters or patient populations.
- A production process that includes unique steps which improve upon previous manufacturing methods.
2. Dependent Claims
These narrow the scope, adding specific features such as:
- Use of particular excipients, carriers, or stabilizers.
- Specific dosage forms (e.g., injectable, oral tablet, topical).
- Particular molecular modifications or dosage regimens.
Patent Claims Specifics
While the exact language of KR20180085049 is necessary for granular analysis, standard patent practice suggests:
- Broad claims attempting to cover the core inventive concept, e.g., a new compound with specific pharmacological activity.
- Narrower claims focusing on particular pharmaceutical formulations or treatment methods.
- The claims likely mention stability, bioavailability, or targeted delivery, common focal points in recent drug patents.
Claim scope implications:
- Enforcement: Strong independent claims provide broad protection but require precise description to withstand validity challenges.
- Infringement: Competitors developing similar formulations or methods may infringe if their products fall within the claim scope.
Patent Landscape in South Korea for Drug Patents
1. Korean Pharmaceutical Patent Environment:
South Korea maintains a robust framework aligned with international standards, with the patent term generally of 20 years from the filing date. The KIPO examines applications for novelty, inventive step, and industrial applicability, leading to a competitive landscape.
2. Key Players & Patent Families:
Major Korean pharmaceutical companies such as Samsung Biologics, Celltrion, and LG Chem actively develop patent portfolios. Many Korean patents are part of global filings, often alongside filings in the U.S., China, and Europe.
3. Patent Strategies:
- Filing core patents early, covering compositions, methods, and manufacturing processes.
- Using patent families for extending protection in multiple jurisdictions.
- Leveraging Korean patent law, including supplementary certificates (SPC-like protections) for certain drug types.
4. Patent Challenges & Litigation Trends:
- Patent challenges often involve claim amendments or invalidation actions.
- Litigation tends to focus on patent validity, especially regarding obviousness and prior art exclusions, particularly from international headline-grabbing patent trolls or generic challengers.
Similar and Related Patent Applications
The landscape features numerous patents related to drug formulations, delivery systems (e.g., nanoparticles, liposomes), and novel APIs. The competition is intense around:
- Biologic and biosimilar innovations.
- Extended-release formulations.
- Methods enhancing bioavailability or patient compliance.
Patent KR20180085049 likely intersects with these areas, especially if it covers novel delivery mechanisms or formulations.
Legal Status and Patent Term
Based on timeframes, the patent, filed in 2018, is approaching or has entered its third year, with expiration estimated in 2038, subject to maintenance fee payments. The legal status should be verified through KIPO’s official patent register for granted or pending status, oppositions, or other legal proceedings.
Strategic Recommendations
- Patent Enforcement: Closely monitor for infringing products and ensure broad claim coverage.
- Patent Expansion: Consider extending protection via divisional applications or filing in other jurisdictions.
- Innovation Continuity: Develop follow-up patents focusing on improvements, new indications, or alternative delivery systems.
- Legal Vigilance: Remain aware of potential nullity or invalidation risks, especially in light of prior art challenges.
Key Takeaways
- Comprehensive claim scope enhances exclusivity but must balance breadth with validity.
- Strategic patent positioning in Korea benefits from aligning claims with global patent strategies.
- Legal status should be regularly monitored, as the patent’s enforceability depends on ongoing maintenance and legal compliance.
- Innovation trends focus on formulations, delivery systems, and new therapeutic uses, aligning KR20180085049 with current industry developments.
- Competitor analysis reveals a densely populated landscape with active filings, necessitating vigilant monitoring and strategic patent management.
FAQs
1. What is the patentable scope of KR20180085049?
It likely covers a novel drug formulation, manufacturing process, or therapeutic method involving specific compounds or combinations, with claims tailored to ensure broad protection within these domains.
2. How does this patent fit within the broader Korean pharmaceutical patent landscape?
KR20180085049 complements existing patents by focusing on specific innovations, aligning with Korea’s strategy of fostering domestic innovation while protecting global market interests through patent portfolios.
3. What are the main challenges in enforcing this patent?
Challenges include validating claim scope against prior art, potential for patent invalidation, and product design around the patent claims. Enforcement also depends on precise claim language and ongoing legal vigilance.
4. How can patent holders extend the protection of KR20180085049?
Through filing divisional or continuation applications, pursuing patent term extensions where applicable, and expanding into international markets via PCT filings.
5. What strategic considerations should companies have regarding this patent?
They should evaluate patent validity regularly, explore licensing opportunities, develop complementary innovations, and monitor market activities for potential infringements or challenges.
References
[1] Korean Intellectual Property Office (KIPO). Patent Register for KR20180085049.
[2] WIPO. Patent Cooperation Treaty (PCT) applications related to drug formulations.
[3] Korean Pharmaceutical Industry Association Reports (2021). Overview of the patent landscape.
[4] Patent Law of Korea. Legal framework governing patent examinations and enforcement.
